Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial Burak Yulug, Ozlem […]
SPEAKER SCHEDULE REGISTRATION January 13, 2025 (Seminar) Dr. Çağatay Aydın – Unraveling drug related electrophysiological footprints using high density neuronal probes Neuropsychiatric and neurodevelopmental diseases manifest […]
SPEAKER SCHEDULE REGISTRATION The three-day event will feature two keynote presentations and catalyst talks on the first day, followed by a roundtable discussion including students to […]